IRIS
ROTI, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 5.093
NA - Nord America 5.089
EU - Europa 3.519
SA - Sud America 719
AF - Africa 271
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 2
Totale 14.702
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.941
SG - Singapore 1.826
CN - Cina 1.332
IT - Italia 1.051
VN - Vietnam 873
BR - Brasile 542
IE - Irlanda 491
HK - Hong Kong 406
SE - Svezia 364
DE - Germania 344
FR - Francia 241
FI - Finlandia 189
NL - Olanda 187
ZA - Sudafrica 170
UA - Ucraina 153
GB - Regno Unito 121
IN - India 112
TR - Turchia 112
RU - Federazione Russa 107
AT - Austria 102
CA - Canada 86
BD - Bangladesh 74
AR - Argentina 67
JP - Giappone 48
IQ - Iraq 44
MX - Messico 39
PH - Filippine 38
KR - Corea 32
PL - Polonia 32
CI - Costa d'Avorio 31
EC - Ecuador 27
BE - Belgio 25
PK - Pakistan 25
ID - Indonesia 24
ES - Italia 23
CO - Colombia 22
TH - Thailandia 20
UZ - Uzbekistan 18
VE - Venezuela 18
CZ - Repubblica Ceca 17
LT - Lituania 15
EG - Egitto 13
TW - Taiwan 13
IR - Iran 12
PY - Paraguay 12
SA - Arabia Saudita 12
TN - Tunisia 12
CL - Cile 11
KE - Kenya 11
MA - Marocco 11
UY - Uruguay 10
DZ - Algeria 9
AU - Australia 8
JM - Giamaica 8
NP - Nepal 8
AZ - Azerbaigian 7
IL - Israele 7
JO - Giordania 7
KZ - Kazakistan 7
PA - Panama 7
RO - Romania 7
PE - Perù 6
CH - Svizzera 5
ET - Etiopia 5
KG - Kirghizistan 5
LU - Lussemburgo 5
MY - Malesia 5
RS - Serbia 5
AE - Emirati Arabi Uniti 4
BG - Bulgaria 4
GR - Grecia 4
HR - Croazia 4
HU - Ungheria 4
LB - Libano 4
OM - Oman 4
SY - Repubblica araba siriana 4
AL - Albania 3
DO - Repubblica Dominicana 3
MD - Moldavia 3
PT - Portogallo 3
BB - Barbados 2
BH - Bahrain 2
BO - Bolivia 2
KH - Cambogia 2
LV - Lettonia 2
NG - Nigeria 2
NO - Norvegia 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
AO - Angola 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CD - Congo 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
EU - Europa 1
GF - Guiana Francese 1
Totale 14.690
Salva come PNG Salva come JPEG
Città #
Singapore 951
Ashburn 750
Dublin 491
San Jose 477
Dallas 474
Chandler 472
Hong Kong 388
Parma 294
Beijing 290
Santa Clara 268
Ho Chi Minh City 257
Boardman 220
Hanoi 195
Johannesburg 160
Jacksonville 135
Ann Arbor 126
Lauterbourg 124
Dearborn 105
Los Angeles 105
Munich 100
Princeton 90
New York 89
Vienna 86
Nanjing 85
Shanghai 81
Milan 73
Izmir 72
Hefei 70
Bologna 67
Wilmington 62
Helsinki 56
São Paulo 55
Grafing 53
Shenyang 51
San Mateo 50
Marseille 49
Jinan 44
Nanchang 43
Moscow 42
Buffalo 40
Haiphong 39
Toronto 39
Chicago 38
Columbus 37
Da Nang 37
Turku 33
Hebei 32
Abidjan 31
Seattle 31
Rome 30
Amsterdam 29
Tokyo 29
Frankfurt am Main 28
Guangzhou 28
Montreal 28
Reggio Emilia 27
Tianjin 26
Changsha 25
Nuremberg 25
Modena 24
Verona 24
The Dalles 23
Des Moines 22
Kunming 22
Seoul 22
Warsaw 22
Brescia 21
Brussels 21
Rio de Janeiro 21
London 20
Pune 20
Atlanta 19
Baghdad 19
Council Bluffs 19
Poplar 19
Bremen 17
Brooklyn 17
Denver 17
Houston 17
Fremont 16
Hải Dương 16
Jiaxing 16
Brasília 15
Jakarta 15
Orem 15
Phoenix 15
Tashkent 15
Bengaluru 14
Biên Hòa 14
West Jordan 14
Norwalk 13
Perugia 13
Zhengzhou 13
Belo Horizonte 12
Brno 12
Chennai 12
Düsseldorf 12
Florence 12
Lahore 12
Mexico City 12
Totale 8.926
Salva come PNG Salva come JPEG
Nome #
Blockade of Oncogenic NOTCH1 with the SERCA Inhibitor CAD204520 in T Cell Acute Lymphoblastic Leukemia 253
Discovery of a new 1-(phenylsulfonyl)-1H-indole derivative targeting the EphA2 receptor with antiproliferative activity on U251 glioblastoma cell line 232
238P Exploring blood immune cell dynamics to unravel the immunomodulatory effect of radiotherapy in NSCLC patients undergoing immune checkpoint inhibitors 216
1328P Dynamic blood immune-inflammatory and radiomic profiling to decode distinct patterns of acquired resistance to immunotherapy in NSCLC patients 214
Morphological, clinical, and molecular profiling of post-polycythemia vera accelerated/blast phase occurring with and without antecedent secondary myelofibrosis 212
Validation of a radiomic approach to decipher NSCLC immune microenvironment in surgically resected patients 209
Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemia 208
227P Sexual dimorphism in immune profile of early and advanced NSCLC 198
Impact of the rs1024611 polymorphism of ccl2 on the pathophysiology and outcome of primary myelofibrosis 185
Targeting oncogenic Notch signaling with SERCA inhibitors 184
189P The parallel interrogation of tissue and peripheral blood immune features unveils a bidirectional crosstalk with clinical impact on resected NSCLC 175
LONGITUDINAL MONITORING OF RADIOMIC AND BLOOD IMMUNE-INFLAMMATORY DESCRIPTORS AS A NON-INVASIVE APPROACH TO PREDICT ICI EFFICACY IN ADVANCED NSCLC PATIENTS 174
Network-based systems pharmacology reveals heterogeneity in LCK and BCL2 signaling and therapeutic sensitivity of T-cell acute lymphoblastic leukemia 170
17P Dynamic changes of CT-radiomic and systemic immune-inflammatory features predict the response to immune checkpoint inhibitors in advanced NSCLC patients 170
Bone marrow endothelial cells carry bcr/abl fusion gene from chronic myeloid leukemia patients 165
Dataset on the identification of a prognostic radio-immune signature in surgically resected Non Small Cell Lung Cancer 164
Dynamic Profiling of Blood Immunophenotypes and Radiomic Features to Predict Immunotherapy Response in Advanced Non-small Cell Lung Cancer 163
2315P Clinical and blood immune-inflammatory profiling to decode different patterns of acquired resistance in immunotherapy treated NSCLC patients 156
Bone marrow endothelial cells carry bcr/abl fusion gene from chronic myeloid leukemia patients 155
Angiopoietins expression by human myeloma cells 154
Longitudinal Changes of CT-radiomic and Systemic Inflammatory Features Predict Survival in Advanced Non–Small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors 151
Bone marrow endothelial cells carry bcr/abl fusion gene from chronic myeloid leukemia patients 151
Identification of the Atypical Protein Kinase WNK1 As a New Target in T-Cell Acute Lymphoblastic Leukemia 147
Hematologic malignancies with extramedullary spread of disease. Case 1. Multiple myeloma with extramedullary involvement of the pleura and testes 147
IL-7 is induced by IL-6 in human myeloma cells: role in multiple myeloma 144
Integrated CT imaging and tissue immune features disclose a radio-immune signature with high prognostic impact on surgically resected NSCLC 144
BCR/ABL fusion gene is detected in chronic myeloid leukemia endothelial cells 144
Pro-angiogenetic properties of human myeloma cells: production of angiopoietin-1 and its potential relationship with myeloma-induced angiogenesis 143
Targeting Notch Trafficking and Processing in Cancers 142
Genetics of Darier’s Disease: New Insights into Pathogenic Mechanisms 141
Acute lymphoblastic leukaemia in Noonan syndrome. 140
CAD204520 Targets NOTCH1 PEST Domain Mutations in Lymphoproliferative Disorders 135
THERAPEUTIC TARGETING OF NOTCH SIGNALING PATHWAY IN HEMATOLOGICAL MALIGNANCIES 135
Human myeloma cells produce angiopoietin-1 but not angiopoietin-2: potential relationship with myeloma-induced angiogenesis 134
Orthogonal Proteogenomic Approaches Identify the Druggable PA2G4-MYC Axis in 3q26 AML 133
14q32 rearrangements deregulating BCL11B mark a distinct subgroup of T-lymphoid and myeloid immature acute leukemia 131
SERCA MODULATION COUNTERACTS GLUCOCORTICOID RESISTANCE IN T-ALL 130
1061P Static and dynamic tracking of radiomic and immunophenotypic features predicts the benefit of immune checkpoint inhibitors in advanced NSCLC 130
Venetoclax and bortezomib in relapsed/refractory early t-cell precursor acute lymphoblastic leukemia 130
BCR/ABL fusion gene is detected in chronic myeloid leukemia endothelial cells 130
Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML 129
Human myeloma cells production of angiopoietin-1 and its potential relationship with myeloma-induced angiogenesis 127
MYB rearrangements and over-expression in T-cell acute lymphoblastic leukemia 127
Strategies to Overcome Resistance Mechanisms in T-Cell Acute Lymphoblastic Leukemia 126
SELECTIVE BLOCKADE OF ONCOGENIC NOTCH1 WITH THE NEW SERCA INHIBITOR CAD204520 125
The Atypical Protein Kinase WNK1 Controls Leukemia Progression in TAL/LMO T-Cell Acute Lymphoblastic Leukemia 124
P1.15-04 Dynamic Profiling of Blood Immunophenotypes and Radiomic Features to Predict Immunotherapy Response in Advanced Non-small Cell Lung Cancer 124
Β-blockers activate autophagy on infantile hemangioma-derived endothelial cells in vitro 123
Acute lymphoblastic leukaemia 123
Activating somatic and germline TERT promoter variants in myeloid malignancies 122
Down-Modulation of Erk Protein Kinase Activity Inhibits Vascular Endothelial Growth Factor (VEGF) Secretion by human Myeloma Cell Lines 121
IL-7 is produced by myeloma cells in presence of IL-6 118
Human myeloma cells production of angiopoietin-1 and its potential relationship with myeloma-induced angiogenesis 118
Haploidentical hematopoietic stem cell transplantation in adults using the αβTCR/CD19-based depletion of G-CSF-mobilized peripheral blood progenitor cells 117
Myb overexpression synergizes with the loss of Pten and is a dependency factor and therapeutic target in T-cell lymphoblastic leukemia 115
VASCULAR ENDOTHELIAL GROWTH FACTOR SECRETION BY MYELOMA CELLS IS INHIBITED BY DOWN-MODULATING ERK PROTEIN KINASE ACTIVITY 115
Osteopontin is produced by human multiple myeloma cells 115
Multiple myeloma patient with unusual extramedullary involvement 114
Down-modulation of ERK protein kinase activity suppresses human myeloma cell proliferation and myeloma-induced angiogenesis by VEGF inhibition 110
Advanced CT imaging features reflect distinct tissue immune profiles and exhibit high prognostic impact on NSCLC 108
A new NDE1/PDGFRB fusion transcript underlying chronic myelomonocytic leukaemia in Noonan Syndrome 108
Multiple Myeloma patient with unusual extramedullary involvement 107
Cryptic chromosome 9q34 deletion generates TAF-Ialpha/CAN and TAF-Ibeta/CAN fusion transcripts in acute myeloid leukemia. 107
Multiple myeloma patient with unusual extramedullary involvement 107
Chemical Genomic Screen Identifies Ionophores as Modulators of Notch1 in T-ALL 107
Paracrine rather than autocrine basic FGF (bFGF) loop in multiple myeloma 106
Down-modulation of ERK protein kinase activity inhibits vascular endothelial growth factor (VEGF) secretion by human myeloma cell lines 106
WO/2016/073708 106
A distinct epigenetic program underlies the 1;7 translocation in myelodysplastic syndromes 105
Bepridil exhibits anti-leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemia 104
Resistance to Epigenetic-Targeted Therapy Engenders Tumor Cell Vulnerabilities Associated with Enhancer Remodeling 104
Selective Blockade of Oncogenic NOTCH1 with the New SERCA Inhibitor CAD204520 in T-cell Acute Lymphoblastic Leukemia 103
Bilateral tonsillar infiltration of T-cell prolymphocytic leukemia 103
Nivolumab-Induced Guillain-Barré Syndrome Coupled With Remarkable Disease Response in a Case of Heavily Pretreated Lung Adenocarcinoma 103
IL-7 is produced by myeloma cells in presence of IL-6 101
Design of a Comprehensive Fluorescence in Situ Hybridization Assay for Genetic Classification of T-Cell Acute Lymphoblastic Leukemia 101
Paracrine rather than autocrine basic FGF (bFGF) loop in multiple myeloma 100
Bone marrow endothelial cells carry BCR/ABL fusion gene from chronic myeloid leukemia patients. 100
Synergistic drug combinations with a CDK4/6 inhibitor in T-cell acute lymphoblastic leukemia 100
Human myeloma cells express IL-7 mRNA and secrete IL-7 in presence of IL-6 99
Genetic and proteomic approaches to identify cancer drug targets. 99
Longitudinal blood immune-inflammatory and radiomic profiling to decode different patterns acquired resistance to immunotherapy in patients with NSCLC 97
Leukemia-specific delivery of mutant NOT CH1 targeted therapy 94
T(10;11)(P13;P14-21) PICALM-MLLT10 ACUTE LEUKEMIA: CHARACTERIZATION OF TWO CASES WITH DIFFERENT PHENOTYPIC PRESENTATION 93
Modern treatment approaches to adult acute T-lymphoblastic and myeloid/T-lymphoblastic leukemia: From current standards to precision medicine 93
Genetic profile of acute lymphoblastic leukemia in a patient with the noonan syndrome 93
FROM GENOMICS TO CHEMOGEGNOMICS IN T CELL ACUTE LYMPHOBLASTIC LEUKEMIA 91
CD26 is differentially expressed throughout the life cycle of infantile hemangiomas and characterizes the proliferative phase 91
Complementary genomic screens identify SERCA as a therapeutic target in NOTCH1 mutated cancer. 89
Characterization of Notch1 antibodies that inhibit signaling of both normal and mutated Notch1 receptors. 87
Differentially regulated high-throughput CT imaging features correlate to distinct tumor immune contextures portraying a radiomic signature with prognostic impact on surgically resected NSCLC 86
e6a2 BCR/ABL1 fusion with cryptic der(9)t(9;22) deletions in a patient with chronic myeloid leukemia 85
Lenvatinib Targets PDGFR-β Pericytes and Inhibits Synergy with Thyroid Carcinoma Cells: Novel Translational Insights 85
Cytoplasmic nucleophosmin in myeloid sarcoma occurring 20 years after diagnosis of acute myeloid leukaemia. 84
Cytogenetic/mutation profile of chronic lymphocytic leukemia/malignant melanoma collision tumors of the skin 84
Down-modulation of ERK protein kinase activity inhibits vascular endothelial growth factor (VEGF) secretion by human myeloma cell lines. 83
Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML. 83
New somatic TERT promoter variants enhance the Telomerase activity in Glioblastoma 81
Targeting the Activating Mutations of NOTCH1 in T-Cell Lymphoblastic Leukemia with a New SERCA Inhibitor CAD204520 80
Vemurafenib-resistance via de novo RBM genes mutations and chromosome 5 aberrations is overcome by combined therapy with palbociclib in thyroid carcinoma with BRAFV600E 80
Totale 12.775
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.789
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.789
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021150 0 0 0 0 0 0 0 0 0 47 78 25
2021/2022517 16 16 11 15 7 64 72 55 27 40 32 162
2022/20231.922 219 191 106 124 206 206 32 117 585 7 82 47
2023/2024987 50 64 29 41 85 184 124 80 40 72 72 146
2024/20253.056 90 164 215 235 337 246 145 137 350 251 275 611
2025/20266.659 582 537 1.006 669 936 440 688 322 976 503 0 0
Totale 14.902